Related Experiment Video
Updated: Jun 19, 2026

08:00
A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
Published on: October 14, 2016
CHEMICAL AND IMMUNOLOGICAL STUDIES ON THE AGENT PRODUCING LEUKOSIS AND SARCOMA OF FOWLS
The Journal of Experimental Medicine
|October 30, 2009
Summary
High-speed centrifugation isolates a tumor-causing agent from crude extracts. This agent, present in normal and leukemic sera and tissues, remains active after irradiation and freezing.
Area of Science:
- Oncology
- Virology
- Biochemistry
Background:
- Sarcoma and leukosis are neoplastic diseases with infectious agents.
- Understanding the physical and chemical properties of these agents is crucial for disease control.
Purpose of the Study:
- To characterize the agent responsible for sarcoma and leukosis.
- To determine the stability and precipitation properties of the infectious agent.
Main Methods:
- High-speed centrifugation of biological materials.
- Tumor induction assays in chickens via injection.
- Analysis of agent activity after irradiation and freezing.
- Precipitation studies using sodium sulfate.
Main Results:
- The agent causing sarcoma/leukosis is sedimentable at high speed and retains activity.
- Tumorigenic activity is observed with as little as 10(-5) mg N of sedimentable material.
- The agent is present in normal and leukemic chicken sera, with higher concentrations in leukemic sera.
- Normal and neoplastic tissues contain significant amounts of the agent.
- Leukemic cells remain infectious after irradiation sufficient to destroy the cells but not the agent.
- The agent is stable for at least 6 months when frozen at -60°C.
- Sodium sulfate precipitation isolates the active agent.
Conclusions:
- The infectious agent for sarcoma and leukosis is a stable entity separable by high-speed centrifugation.
- The agent's presence in various tissues and sera suggests a systemic nature.
- Irradiation resistance and stability under freezing indicate a robust viral or similar structure.

